This study is designed to measure the short-term effects of a growth promoting hormone, recombinant DNA synthesized human insulin-like growth factor-I on the body's handling of glucose, amino acids and protein. These studies will be carried out in chronic kidney failure patients undergoing maintenance hemodialysis and in normal adults.
Showing the most recent 10 out of 1232 publications